Albemarle (NYSE:ALB) Posts Quarterly Earnings Results, Beats Expectations By $1.71 EPS

Albemarle (NYSE:ALB) released its quarterly earnings results on Wednesday. The specialty chemicals company reported $2.95 EPS for the quarter, beating the consensus estimate of $1.24 by $1.71, FiscalAI reports. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion. Albemarle had a negative net margin of 10.74% and a positive return on equity of 0.41%.

Albemarle Stock Down 0.6%

Shares of Albemarle stock traded down $1.08 during trading hours on Wednesday, reaching $193.74. 2,199,674 shares of the company were exchanged, compared to its average volume of 2,574,240. Albemarle has a 1 year low of $53.70 and a 1 year high of $215.71. The stock’s fifty day moving average is $179.01 and its 200 day moving average is $152.97. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.57 and a current ratio of 2.23. The firm has a market cap of $22.84 billion, a PE ratio of -33.69, a PEG ratio of 1.37 and a beta of 1.36.

Albemarle Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Friday, June 12th will be given a dividend of $0.405 per share. The ex-dividend date of this dividend is Friday, June 12th. This represents a $1.62 dividend on an annualized basis and a dividend yield of 0.8%. Albemarle’s dividend payout ratio is currently -28.17%.

Insider Buying and Selling at Albemarle

In other news, CEO J Kent Masters sold 11,783 shares of the company’s stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $170.81, for a total transaction of $2,012,654.23. Following the sale, the chief executive officer owned 134,628 shares of the company’s stock, valued at approximately $22,995,808.68. This represents a 8.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.42% of the company’s stock.

Institutional Trading of Albemarle

Large investors have recently modified their holdings of the stock. Tiemann Investment Advisors LLC purchased a new stake in shares of Albemarle during the fourth quarter worth $218,000. J.W. Cole Advisors Inc. acquired a new position in shares of Albemarle during the fourth quarter worth $211,000. Sepio Capital LP acquired a new position in shares of Albemarle during the fourth quarter worth $211,000. Cim Investment Management Inc. acquired a new position in shares of Albemarle during the fourth quarter worth $204,000. Finally, Axxcess Wealth Management LLC acquired a new position in shares of Albemarle during the fourth quarter worth $202,000. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Albemarle News Summary

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Q1 results materially beat expectations — Albemarle reported EPS of $2.95 vs. the Zacks consensus of $1.24 and revenue of $1.43B vs. ~$1.34B, showing stronger-than-expected top- and bottom-line performance this quarter. Albemarle (ALB) Tops Q1 Earnings and Revenue Estimates
• Positive Sentiment: Analysts revised forecasts ahead of the call — several of the most accurate analysts raised estimates going into the release, reflecting improving near-term expectations for lithium demand and pricing. Albemarle earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call
• Positive Sentiment: Board declared a quarterly dividend of $0.405/share (annualized $1.62), supporting income-oriented investors and signaling cash-return discipline. Ex-dividend date is June 12. Albemarle Announces Quarterly Common Stock Dividend
• Neutral Sentiment: FY‑2026 revenue guidance roughly in line with expectations — the company set revenue guidance around $5.7B–$6.0B, which tracks consensus, but EPS guidance details were unclear/limited in the release, leaving some forward clarity missing. Albemarle Reports First Quarter 2026 Results
• Negative Sentiment: Profitability and margin scrutiny — despite the beat, the company reported a negative net margin (and historical negative P/E), indicating earnings volatility or one-time items that may temper enthusiasm about sustainable profitability. Investors may be cautious until margins consistently normalize. Compared to Estimates, Albemarle (ALB) Q1 Earnings: A Look at Key Metrics

Wall Street Analyst Weigh In

ALB has been the topic of several analyst reports. Oppenheimer lifted their price target on shares of Albemarle from $216.00 to $222.00 and gave the company an “outperform” rating in a research report on Monday, April 13th. BMO Capital Markets boosted their target price on Albemarle from $145.00 to $210.00 and gave the company an “outperform” rating in a research report on Tuesday, January 20th. Mizuho boosted their target price on Albemarle from $156.00 to $185.00 and gave the company a “neutral” rating in a research report on Thursday, February 12th. Morgan Stanley boosted their target price on Albemarle from $170.00 to $189.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 28th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Albemarle from $185.00 to $195.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Thirteen investment analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Albemarle presently has a consensus rating of “Hold” and a consensus target price of $183.00.

Albemarle Company Profile

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.